Impact Factor 2021: 3.041 (@Clarivate Analytics)
5-Year Impact Factor: 2.776 (@Clarivate Analytics)
Impact Factor Rank: 10/24, Q2 (Tropical Medicine)
  • Users Online: 1553
  • Print this page
  • Email this page
This article has been cited by
1Non-effectiveness of Ivermectin on Inpatients and Outpatients With COVID-19; Results of Two Randomized, Double-Blinded, Placebo-Controlled Clinical Trials
Mohammad Sadegh Rezai,Fatemeh Ahangarkani,Andrew Hill,Leah Ellis,Manya Mirchandani,Alireza Davoudi,Gohar Eslami,Fatemeh Roozbeh,Farhang Babamahmoodi,Nima Rouhani,Ahmad Alikhani,Narges Najafi,Roya Ghasemian,Hossein Mehravaran,Azin Hajialibeig,Mohammad Reza Navaeifar,Leila Shahbaznejad,Golnar Rahimzadeh,Majid Saeedi,Reza Alizadeh-Navai,Mahmood Moosazadeh,Shahab Saeedi,Seyedeh-Kiana Razavi-Amoli,Shaghayegh Rezai,Fereshteh Rostami-Maskopaee,Fatemeh Hosseinzadeh,Faezeh Sadat Movahedi,John S. Markowitz,Reza Valadan
Frontiers in Medicine.2022;9()
[DOI]
2Meta-Analyses Do Not Establish Improved Mortality With Ivermectin Use in COVID-19
Steven G. Rothrock,Kurt D. Weber,Philip A. Giordano,Mitchell D. Barneck
American Journal of Therapeutics.2022;29(1)e87
[DOI]
3Efficacy and safety of ivermectin in patients with mild and moderate COVID-19: A randomized controlled trial
Alireza Malektojari,Sara Ghazizadeh,MohammadHamed Ersi,Elham Brahimi,Soheil Hassanipour,Mohammad Fathalipour,Mehdi Hassaniazad
Asian Pacific Journal of Tropical Medicine.2023;16(1)3
[DOI]